Embracing and conquering challenges through forward-thinking strategic and tactical solutions is my passion. My specialty is serving as a strategic business partner and operationally focused financial advisor to C-suite and key decision-makers within PE-backed and global publicly held environments. A transformative leader and powerful listener, I play a critical role in influencing business strategy, corporate value, and organic/inorganic growth across varied industries. These include high-tech, manufacturing, biotechnology, pharmaceutical, and life sciences, among others. Leveraging a progressive career as CFO, COO and General Manager, I drive positive disruptive change across organizations by identifying, developing, and mentoring talent, instilling accountability, and driving outcomes that align with corporate goals and vision. Noted for:TransformationPositioned portfolio company for exponential growth following acquisition of 33-year-old, founder-run company by private equity.Future GrowthAppointed by PE sponsor to serve as de facto CEO to remedy legal and industry-driven challenges that resulted in declining revenue. Repositioned company for future and sustainable growth by resolving legacy issues, obtaining two critical industry certifications, acquiring and integrating seven geographically dispersed companies, settling lawsuits at a fraction of initial claims, and overseeing the transition of headquarters across the U.S. Crisis ManagementAnalyzed, created, and developed protocols and strategies to mitigate the impact of the COVID-19 pandemic, after which the Company was awarded major federal and state contracts requiring the rapid ramp-up of operations and hiring of 75 additional personnel, resulting in exponential growth.TurnaroundReversed declining operating results at a PE-backed, global provider of technology and services for the healthcare industry through large-scale restructuring.Market PositionSolidified, for a global public company operating in six countries – Europe and Asia, market share of the $1B test and measurement market with the acquisition of a US-based public protocol analyzer company.Executive Strengths for Key Business ImpactStrategic and Tactical Planning and Execution − Banking Relationships − Audit − Treasury − Governance − Investor Relations − M&A − Due Diligence − Integrations − SAP Implementation − Complex Deal Structuring − High-level Negotiations − Human Resources − Crisis Management − Global Initiatives − Board of Director Interface − Financial and Operational Leadership